Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Short-term Investments (2024 - 2025)

China SXT Pharmaceuticals (SXTC) has 2 years of Short-term Investments data on record, last reported at $30413.0 in Q1 2025.

  • For Q1 2025, Short-term Investments rose 344.5% year-over-year to $30413.0; the TTM value through Mar 2025 reached $30413.0, up 344.5%, while the annual FY2025 figure was $30413.0, 344.5% up from the prior year.
  • Short-term Investments reached $30413.0 in Q1 2025 per SXTC's latest filing, up from $6842.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $30413.0 in Q1 2025 and bottomed at $6842.0 in Q1 2024.